174 related articles for article (PubMed ID: 7568087)
1. Fungal metabolic model for human type I hereditary tyrosinaemia.
Fernández-Cañón JM; Peñalva MA
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9132-6. PubMed ID: 7568087
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of a gene encoding a homogentisate dioxygenase from Aspergillus nidulans and identification of its human and plant homologues.
Fernández-Cañón JM; Peñalva MA
J Biol Chem; 1995 Sep; 270(36):21199-205. PubMed ID: 7673153
[TBL] [Abstract][Full Text] [Related]
3. Alkaptonuria: from humans to moulds and back.
Scazzocchio C
Trends Genet; 1997 Apr; 13(4):125-7. PubMed ID: 9097720
[No Abstract] [Full Text] [Related]
4. Spectrophotometric determination of homogentisate using Aspergillus nidulans homogentisate dioxygenase.
Fernández-Cañón JM; Peñalva MA
Anal Biochem; 1997 Feb; 245(2):218-21. PubMed ID: 9056215
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional analysis of mutations in alkaptonuria.
Rodríguez JM; Timm DE; Titus GP; Beltrán-Valero De Bernabé D; Criado O; Mueller HA; Rodríguez De Córdoba S; Peñalva MA
Hum Mol Genet; 2000 Sep; 9(15):2341-50. PubMed ID: 11001939
[TBL] [Abstract][Full Text] [Related]
6. Complete rescue of lethal albino c14CoS mice by null mutation of 4-hydroxyphenylpyruvate dioxygenase and induction of apoptosis of hepatocytes in these mice by in vivo retrieval of the tyrosine catabolic pathway.
Endo F; Kubo S; Awata H; Kiwaki K; Katoh H; Kanegae Y; Saito I; Miyazaki J; Yamamoto T; Jakobs C; Hattori S; Matsuda I
J Biol Chem; 1997 Sep; 272(39):24426-32. PubMed ID: 9305902
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I.
Grompe M; Lindstedt S; al-Dhalimy M; Kennaway NG; Papaconstantinou J; Torres-Ramos CA; Ou CN; Finegold M
Nat Genet; 1995 Aug; 10(4):453-60. PubMed ID: 7545495
[TBL] [Abstract][Full Text] [Related]
8. Disruption of fumarylacetoacetate hydrolase causes spontaneous cell death under short-day conditions in Arabidopsis.
Han C; Ren C; Zhi T; Zhou Z; Liu Y; Chen F; Peng W; Xie D
Plant Physiol; 2013 Aug; 162(4):1956-64. PubMed ID: 23743712
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I: overview.
St-Louis M; Tanguay RM
Hum Mutat; 1997; 9(4):291-9. PubMed ID: 9101289
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a fungal maleylacetoacetate isomerase gene and identification of its human homologue.
Fernández-Cañón JM; Peñalva MA
J Biol Chem; 1998 Jan; 273(1):329-37. PubMed ID: 9417084
[TBL] [Abstract][Full Text] [Related]
11. A case of tyrosinaemia type I with normal level of succinylacetone in the amniotic fluid.
Grenier A; Cederbaum S; Laberge C; Gagné R; Jakobs C; Tanguay RM
Prenat Diagn; 1996 Mar; 16(3):239-42. PubMed ID: 8710777
[TBL] [Abstract][Full Text] [Related]
12. A mouse model of renal tubular injury of tyrosinemia type 1: development of de Toni Fanconi syndrome and apoptosis of renal tubular cells in Fah/Hpd double mutant mice.
Sun MS; Hattori S; Kubo S; Awata H; Matsuda I; Endo F
J Am Soc Nephrol; 2000 Feb; 11(2):291-300. PubMed ID: 10665936
[TBL] [Abstract][Full Text] [Related]
13. The molecular basis of alkaptonuria.
Fernández-Cañón JM; Granadino B; Beltrán-Valero de Bernabé D; Renedo M; Fernández-Ruiz E; Peñalva MA; Rodríguez de Córdoba S
Nat Genet; 1996 Sep; 14(1):19-24. PubMed ID: 8782815
[TBL] [Abstract][Full Text] [Related]
14. Genotyping of a case of tyrosinaemia type I with normal level of succinylacetone in amniotic fluid.
Poudrier J; Lettre F; St-Louis M; Tanguay RM
Prenat Diagn; 1999 Jan; 19(1):61-3. PubMed ID: 10073910
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report.
Grompe M; Overturf K; al-Dhalimy M; Finegold M
J Inherit Metab Dis; 1998 Aug; 21(5):518-31. PubMed ID: 9728332
[TBL] [Abstract][Full Text] [Related]
16. Metabolic studies in a mouse model of hepatorenal tyrosinemia: absence of perinatal abnormalities.
Collins JC; Buchanan DN; Thoene JG; Erickson RP; Brooks SS; Gluecksohn-Waelsch S
Biochem Biophys Res Commun; 1992 Aug; 187(1):340-6. PubMed ID: 1520318
[TBL] [Abstract][Full Text] [Related]
17. Mutation and polymorphism analysis of the human homogentisate 1, 2-dioxygenase gene in alkaptonuria patients.
Beltrán-Valero de Bernabé D; Granadino B; Chiarelli I; Porfirio B; Mayatepek E; Aquaron R; Moore MM; Festen JJ; Sanmartí R; Peñalva MA; de Córdoba SR
Am J Hum Genet; 1998 Apr; 62(4):776-84. PubMed ID: 9529363
[TBL] [Abstract][Full Text] [Related]
18. Identification of a stop mutation in five Finnish patients suffering from hereditary tyrosinemia type I.
St-Louis M; Leclerc B; Laine J; Salo MK; Holmberg C; Tanguay RM
Hum Mol Genet; 1994 Jan; 3(1):69-72. PubMed ID: 8162054
[TBL] [Abstract][Full Text] [Related]
19. Tyrosinaemia type I and apoptosis of hepatocytes and renal tubular cells.
Endo F; Sun MS
J Inherit Metab Dis; 2002 May; 25(3):227-34. PubMed ID: 12137232
[TBL] [Abstract][Full Text] [Related]
20. Molecular Aspects of the FAH Mutations Involved in HT1 Disease.
Morrow G; Angileri F; Tanguay RM
Adv Exp Med Biol; 2017; 959():25-48. PubMed ID: 28755182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
